标题
New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 168, Issue 3, Pages 554-575
出版商
Wiley
发表日期
2012-09-21
DOI
10.1111/j.1476-5381.2012.02223.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Functional efficacy of adenosine A2A receptor agonists is positively correlated to their receptor residence time
- (2012) Dong Guo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor
- (2012) S. Mary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biased Signaling Pathways in 2-Adrenergic Receptor Characterized by 19F-NMR
- (2012) J. J. Liu et al. SCIENCE
- A Simple Method for Quantifying Functional Selectivity and Agonist Bias
- (2011) Terry Kenakin et al. ACS Chemical Neuroscience
- Greatly enhanced detection of a volatile ligand at femtomolar levels using bioluminescence resonance energy transfer (BRET)
- (2011) Helen Dacres et al. BIOSENSORS & BIOELECTRONICS
- The subtleties of µ-opioid receptor phosphorylation
- (2011) Eamonn Kelly BRITISH JOURNAL OF PHARMACOLOGY
- Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies
- (2011) Christian Doll et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guide to Receptors and Channels (GRAC), 5th edition
- (2011) SPH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- G Protein–Dependent and G Protein–Independent Signaling Pathways and Their Impact on Cardiac Function
- (2011) Douglas G. Tilley CIRCULATION RESEARCH
- Biased Ligands for Better Cardiovascular Drugs
- (2011) Scott M. DeWire et al. CIRCULATION RESEARCH
- Cardiorenal Actions of TRV120027, a Novel ß-Arrestin–Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines
- (2011) Guido Boerrigter et al. Circulation-Heart Failure
- The Antidepressant Desipramine Is an Arrestin-biased Ligand at the α2A-Adrenergic Receptor Driving Receptor Down-regulationin Vitroandin Vivo
- (2011) Christopher Cottingham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quantifying Ligand Bias at Seven-Transmembrane Receptors
- (2011) S. Rajagopal et al. MOLECULAR PHARMACOLOGY
- Developing Chemical Genetic Approaches to Explore G Protein-Coupled Receptor Function: Validation of the Use of a Receptor Activated Solely by Synthetic Ligand (RASSL)
- (2011) E. Alvarez-Curto et al. MOLECULAR PHARMACOLOGY
- Crystal structure of the β2 adrenergic receptor–Gs protein complex
- (2011) Søren G. F. Rasmussen et al. NATURE
- Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
- (2011) J. A. Allen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantitative Encoding of the Effect of a Partial Agonist on Individual Opioid Receptors by Multisite Phosphorylation and Threshold Detection
- (2011) E. K. Lau et al. Science Signaling
- Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium
- (2010) Chang Lau et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Ligand-directed signalling at β-adrenoceptors
- (2010) Bronwyn A. Evans et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impact of species variability and ‘probe-dependence’ on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor
- (2010) S Suratman et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential G-protein-coupled Receptor Phosphorylation Provides Evidence for a Signaling Bar Code
- (2010) Adrian J. Butcher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional Selectivity and Biased Receptor Signaling
- (2010) T. Kenakin JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Selectively Engaging -Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance
- (2010) J. D. Violin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Agonist-Biased Signaling at the Histamine H4 Receptor: JNJ7777120 Recruits -Arrestin without Activating G Proteins
- (2010) E. M. Rosethorne et al. MOLECULAR PHARMACOLOGY
- Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D2L Receptor
- (2010) N. Tschammer et al. MOLECULAR PHARMACOLOGY
- Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening
- (2010) C. Koole et al. MOLECULAR PHARMACOLOGY
- Quantification of Functional Selectivity at the Human 1A-Adrenoceptor
- (2010) B. A. Evans et al. MOLECULAR PHARMACOLOGY
- Deconvolution of complex G protein–coupled receptor signaling in live cells using dynamic mass redistribution measurements
- (2010) Ralf Schröder et al. NATURE BIOTECHNOLOGY
- Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs
- (2010) Shuyun Dong et al. Nature Protocols
- Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
- (2010) T. Kenakin et al. PHARMACOLOGICAL REVIEWS
- Global phosphorylation analysis of -arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR)
- (2010) K. Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
- (2009) John David Norris et al. CHEMISTRY & BIOLOGY
- β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
- (2009) Robert W. Walters et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic Deletion of p90 Ribosomal S6 Kinase 2 Alters Patterns of 5-Hydroxytryptamine2A Serotonin Receptor Functional Selectivity
- (2009) R. T. Strachan et al. MOLECULAR PHARMACOLOGY
- Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors
- (2009) L. P. Pellissier et al. MOLECULAR PHARMACOLOGY
- Exploring the Mechanism of Agonist Efficacy: A Relationship between Efficacy and Agonist Dissociation Rate at the Muscarinic M3 Receptor
- (2009) D. A. Sykes et al. MOLECULAR PHARMACOLOGY
- Cellular assays as portals to seven-transmembrane receptor-based drug discovery
- (2009) Terry P. Kenakin NATURE REVIEWS DRUG DISCOVERY
- Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
- (2009) D. A. Zidar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A -Arrestin-Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
- (2009) D. Gesty-Palmer et al. Science Translational Medicine
- ‘7TM Receptor Allostery: Putting Numbers to Shapeshifting Proteins
- (2009) Terry P. Kenakin TRENDS IN PHARMACOLOGICAL SCIENCES
- Gα-Subunits Differentially Alter the Conformation and Agonist Affinity of κ-Opioid Receptors†
- (2008) Feng Yan et al. BIOCHEMISTRY
- Kinetics of G-protein-coupled receptor signals in intact cells
- (2008) M J Lohse et al. BRITISH JOURNAL OF PHARMACOLOGY
- G-protein-coupled receptor phosphorylation: where, when and by whom
- (2008) A B Tobin BRITISH JOURNAL OF PHARMACOLOGY
- Molecular mechanism of Zn2+agonism in the extracellular domain of GPR39
- (2008) Laura Storjohann et al. FEBS LETTERS
- Ribosomal S6 Kinase 2 Directly Phosphorylates the 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptor, Thereby Modulating 5-HT2ASignaling
- (2008) Ryan T. Strachan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selectivity of Agonists for the Active State of M1 to M4 Muscarinic Receptor Subtypes
- (2008) K. W. Figueroa et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Fluorescence Resonance Energy Transfer Analysis of 2a-Adrenergic Receptor Activation Reveals Distinct Agonist-Specific Conformational Changes
- (2008) A. Zurn et al. MOLECULAR PHARMACOLOGY
- Conformational Rearrangements and Signaling Cascades Involved in Ligand-Biased Mitogen-Activated Protein Kinase Signaling through the 1-Adrenergic Receptor
- (2008) S. Galandrin et al. MOLECULAR PHARMACOLOGY
- Estimation of Relative Microscopic Affinity Constants of Agonists for the Active State of the Receptor in Functional Studies on M2 and M3 Muscarinic Receptors
- (2008) J. A. Tran et al. MOLECULAR PHARMACOLOGY
- Engineering GPCR signaling pathways with RASSLs
- (2008) Bruce R Conklin et al. NATURE METHODS
- Engineered GPCRs as Tools to Modulate Signal Transduction
- (2008) Ying Pei et al. PHYSIOLOGY
- Distinct conformational changes in -arrestin report biased agonism at seven-transmembrane receptors
- (2008) A. K. Shukla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Location, location, location…site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling
- (2008) Andrew B. Tobin et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ligand-Stabilized Conformational States of Human β2 Adrenergic Receptor: Insight into G-Protein-Coupled Receptor Activation
- (2007) Supriyo Bhattacharya et al. BIOPHYSICAL JOURNAL
- Pharmacological Onomastics: What's in a name?
- (2007) T P Kenakin BRITISH JOURNAL OF PHARMACOLOGY
- Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling
- (2007) Teodora Georgieva et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Multiple diverse ligands binding at a single protein site: A matter of pre-existing populations
- (2002) Buyong Ma et al. PROTEIN SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search